Brief: Ajanta Pharma Says Formulation Facility At Dahej Inspected By US FDA
Sept 12 (Reuters) - Ajanta Pharma Ltd AJPH.NS :
* FORMULATION FACILITY AT DAHEJ WAS INSPECTED BY US FDA
* AT END OF FDA INSPECTION, FORM 483 WAS ISSUED WITH 2
PROCEDURAL
OBSERVATIONS
Source text for Eikon: ID:nBSEY62Px
Further company coverage: AJPH.NS
((Reutersbriefs@thomsonreuters.com;))
Recent news on Ajanta Pharma
See all newsIndia's Ajanta Pharma falls as analysts say growth to moderate in H2
Brief: Ajanta Pharma Limited Sept-Quarter Consol Net Profit 3.88 Billion Rupees
India's Ajanta Pharma jumps on June quarter profit jump
Brief: Ajanta Pharma June-Quarter Consol PAT 3.34 Billion Rupees
Brief: Ajanta Pharma Receives US FDA Establishment Inspection Report For Paithan Facility